2 completed, 2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow HIV Lipodystrophy Syndrome: new trials by email Literature Review of HIV Lipodystrophy Syndrome trials Research Report on HIV Lipodystrophy Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Body Composition and Adipose Tissue in HIV Tesamorelin - HIV Lipodystrophy Syndrome, Growth Hormone Deficiency | Phase 4 | Terminated | Columbia University | 6 | 2018-02-07 | 2026-05-19 |
| Energy Expenditure of People Living With HIV/AIDS use of lipid-lowering drugs. - HIV/AIDS, HIV Lipodystrophy Syndrome | Completed | University of Sao Paulo General Hospital | 45 | 2013-03-01 | 2015-08-21 | |
| A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth HIV Infections, HIV-Associated Lipodystrophy Syndrome | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 450 | 2003-10-01 | 2014-01-07 | |
| Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors, protease inhibitors - HIV Infections, HIV Lipodystrophy Syndrome | Phase 4 | Terminated | French National Agency for Research on AIDS and Viral Hepatitis | 100 | 2001-01-01 | 2005-11-15 |
HIV-Associated Lipodystrophy Syndrome (4) · HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · Bone Diseases, Metabolic (1) · Dwarfism, Pituitary (1) · Dyslipidemias (1) · Lipodystrophy (1) · Osteoporosis (1)
Blood-Borne Infections (4) · Communicable Diseases (4) · Genital Diseases (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Infections (4) · Lentivirus Infections (4) · Lipid Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · RNA Virus Infections (4) · Retroviridae Infections (4) · Sexually Transmitted Diseases (4) · Sexually Transmitted Diseases, Viral (4) · Skin Diseases (4)
Fibric Acids (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Protease Inhibitors (1) · tesamorelin (1)
Columbia University (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Sao Paulo General Hospital (1)
United States (2) · France (1) · Puerto Rico (1)
Dominique Costagliola (1) · Grace Aldrovandi, MD (1) · Marc Antoine Valantin, MD (1) · Pamela U. Freda, MD (1) · Peggy Borum, PhD (1)
R01DK110771 (1)